financetom
Business
financetom
/
Business
/
Blake Lively seeks dismissal of Justin Baldoni's $400 million defamation lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blake Lively seeks dismissal of Justin Baldoni's $400 million defamation lawsuit
Mar 20, 2025 10:29 AM

NEW YORK, March 20 (Reuters) -

Actress Blake Lively on Thursday asked a U.S. judge to

dismiss actor Justin Baldoni's $400 million defamation lawsuit,

calling it a "vengeful and rambling" case that does not belong

in federal court.

In a filing in Manhattan federal court, Lively said "the

law prohibits weaponizing defamation lawsuits" such as Baldoni's

to retaliate against people who have spoken out publicly and in

court about sexual harassment and retaliation.

She is also seeking unspecified triple and punitive

damages for the reputational and emotional harm that Baldoni and

the other defendants allegedly caused.

Baldoni and Lively have forcefully denied each other's

respective allegations. Lawyers for Baldoni did not immediately

respond to requests for comment.

Lively and Baldoni have feuded publicly since December, when

Lively accused him of sexually harassing her while filming the

2024 movie "It Ends With Us," in which Baldoni co-starred and

directed, and then trying to tarnish her reputation.

Litigation began when Lively filed a complaint with the

California Civil Rights Department, followed by her own lawsuit

in the Manhattan court.

Baldoni and his production company Wayfarer Studios

countersued, accusing Lively, her husband Ryan Reynolds, their

publicist, the New York Times ( NYT ) and others of

orchestrating a smear campaign to extort him.

He accused Lively of trying to "hijack" the movie, whose

themes included domestic violence, and then blame him when her

"disastrous" promotional approach prompted an online backlash

against her.

A March 2026 trial is scheduled.

Reynolds is also seeking a dismissal of Baldoni's lawsuit.

In a Tuesday court filing, Reynolds said the defamation case

reflected "hurt feelings" based on the two times he allegedly

called Baldoni a "predator."

Reynolds also said he "genuinely, perhaps passionately,

believes" Baldoni's behavior reflects that of a predator, and

that using the word is constitutionally protected opinion.

The Times, meanwhile, said it was merely doing journalism

when it published the December 21, 2024 article "'We Can Bury

Anyone': Inside a Hollywood Smear Machine" about Lively and

Baldoni, and was not helping Lively extract revenge.

U.S. District Judge Lewis Liman in Manhattan, who oversees

both lawsuits, has signaled Baldoni is likely to lose his case

against the Times.

"It Ends With Us" garnered mixed reviews, but grossed more

than $351 million worldwide according to Box Office Mojo.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's Mitsui could study Alaska LNG project, no decisions made, CFO says
Japan's Mitsui could study Alaska LNG project, no decisions made, CFO says
Feb 3, 2025
TOKYO, Feb 4 (Reuters) - Japanese trading house Mitsui ( MITSF ) could consider studying a project to liquefy natural gas in Alaska in the United States, Chief Financial Officer Tetsuya Shigeta, said on Tuesday, adding that no decisions had been made. Shigeta also said he hoped that a planned meeting between Japan's Prime Minister Shigeru Ishiba and U.S. President...
Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Feb 3, 2025
LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid a lack of clarity over trial results that hammered its shares in December. Novo believes CagriSema could be more powerful than its blockbuster weight-loss injection Wegovy, but investors are worried whether it will be good enough to retake...
Citi sticks to hybrid working, bucks return-to-office trend, FT reports
Citi sticks to hybrid working, bucks return-to-office trend, FT reports
Feb 3, 2025
(Reuters) - Citigroup ( C/PN ) CEO Jane Fraser has informed top executives that the bank will continue to allow most employees to work remotely at least two days a week, Financial Times reported on Tuesday. Fraser promised to continue the hybrid work schedule on a quarterly call with the bank's managing directors in mid-January, the newspaper reported, citing people...
BNP Paribas beats Q4 forecast but trims 2025 profit target
BNP Paribas beats Q4 forecast but trims 2025 profit target
Feb 3, 2025
PARIS (Reuters) -France's BNP Paribas reported a forecast-beating jump in net income in the fourth quarter as its investment bankers rode a surge in trading activity, but the lender lowered a key profit target for 2025 and said it would cut costs further. The euro zone's biggest bank by assets said group net income rose by 15.7% to 2.32 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved